FDA cleared Tregzi to improve chronic GVHD-free survival, representing a non-pharmacologic strategy to reduce chronic GVHD while supporting immune reconstitution after allogeneic transplantation.
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...
The human microbiome is essential to our health, but scientists have only begun to understand why. Two researchers set out to ...
Justin Gaethje’s fighting career came full circle under a pair of night skies nearly two decades apart. In 2008, Gaethje had ...
Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals for $10 billion cash, in a deal that would expand the ...
Domestic biohealth companies are set to target the global market using the Texas Medical Center (TMC), the world's largest ...
Bonta’s office said the case started when a couple who lost their home in the Eaton Fire applied to rent a property listed by ...
Stacker used information from IMDb to rank the worst movies of the '90s. The rankings are based on user reviews from the ...
First in a three-part series. This story was produced with support from the Pulitzer Center. In the past four springs, state employees in small planes and a helicopter have combed the skies of ...
Eisai Co., Ltd. and Biogen Inc. announced today that new data presented at the Alzheimer's Association International Conference® (AAIC®) 2026 in London support that the LEQEMBI® (lecanemab) ...
California could begin testing students as early as kindergarten in math if a bill currently going through the state ...
Vertex Pharma to buy Crinetics Pharmaceuticals for $10 billion: Boston Wednesday, July 8, 2026, 14:00 Hrs [IST] Vertex Pharmaceuticals Incorporated, a global biotechnology company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results